Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Revenue: 2010-2025

Historic Revenue for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $26.1 million.

  • OptimizeRx's Revenue rose 2232.86% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.5 million, marking a year-over-year increase of 2418.46%. This contributed to the annual value of $92.1 million for FY2024, which is 2880.93% up from last year.
  • As of Q3 2025, OptimizeRx's Revenue stood at $26.1 million, which was up 2232.86% from $29.2 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Revenue registered a high of $32.3 million during Q4 2024, and its lowest value of $11.2 million during Q1 2021.
  • Its 5-year average for Revenue is $19.2 million, with a median of $18.8 million in 2024.
  • As far as peak fluctuations go, OptimizeRx's Revenue plummeted by 644.62% in 2022, and later skyrocketed by 5519.35% in 2025.
  • Over the past 5 years, OptimizeRx's Revenue (Quarter) stood at $20.3 million in 2021, then fell by 3.24% to $19.7 million in 2022, then soared by 44.34% to $28.4 million in 2023, then increased by 13.91% to $32.3 million in 2024, then fell by 19.34% to $26.1 million in 2025.
  • Its Revenue stands at $26.1 million for Q3 2025, versus $29.2 million for Q2 2025 and $21.9 million for Q1 2025.